World news, news around town, tech update 3
Ad
Tuesday, 20 September 2016
Allergan buys second fatty liver-disease company
(Reuters) - Allergan Inc on Tuesday said it had paid $50 million for Akarna Therapeutics Ltd, a privately held company developing treatments for a incurable fatty liver disease called NASH.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment